| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |